OncoVee™-MiniPDX-guided anticancer treatment for HER2-negative intermediate-advanced gastric cancer patients: a single-arm, open-label phase I clinical study

Abstract Background Chemotherapy is the main treatment strategy for patients with advanced HER2-negative gastric cancer (GC); yet, many patients do not respond well to treatment. This study evaluated the sensitivity of a mini patient-derived xenograft (MiniPDX) animal model in patients with HER2-neg...

Descripció completa

Dades bibliogràfiques

Autors principals:	Baonan Zhang, Yuzhen Li, Xiaodan Zhu, Zhe Chen, Xiaona Huang, Tingjie Gong, Weiwang Zheng, Zhenle Bi, Chenyang Zhu, Jingyi Qian, Xiaoqiang Li, Chunhui Jin
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer 2023-04-01
Col·lecció:	Discover Oncology
Matèries:	Mini patient-derived xenograft (MiniPDX) animal model Gastric cancer Progression-free survival (PFS) Survival time Response
Accés en línia:	https://doi.org/10.1007/s12672-023-00661-y
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!